Kallyope
New York City
New York
United States
28 articles about Kallyope
-
Kallyope Inc. Appoints Brett Lauring As Chief Medical Officer
2/5/2019
Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, announced that it has appointed Brett Lauring, M.D., Ph.D.
-
Kallyope Inc. Announces $21 Million Expansion of Series B Financing
12/5/2018
Entry of Bill Gates and additional investment from existing syndicate raises Series B total to $87 million
-
Kallyope and Novo Nordisk Announce Collaboration to Discover Novel Therapeutics for Obesity and Diabetes
6/19/2018
Kallyope Inc. and Novo Nordisk A/S announced that they have entered into a research collaboration and option agreement to discover novel peptide therapeutics to treat obesity and diabetes.
-
New York-based Kallyope and Danish company Novo Nordisk A/S signed a research collaboration and option deal to discover novel therapeutics to treat obesity and diabetes.
-
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
2/22/2018
All existing backers including Lux Capital, The Column Group, and Polaris Partners joined by new investors Euclidean Capital and Two Sigma Ventures
-
New York-based Kallyope Inc. has secured an additional $66 million in Series B funding that it will use to continue its work harnessing the communicative pathways between the digestive tract and the brain to develop new therapies for various illnesses.
-
Kallyope Appoints Ann E. Weber And William J. Rieflin To Key Roles
10/27/2016
-
New York Biotech Kallyope Launches with $44 Million and a Merck & Co. Vet at Its Helm
12/11/2015